The Adverse Outcome Pathway: A Multifaceted Framework Supporting 21st Century Toxicology.

The adverse outcome pathway (AOP) framework serves as a knowledge assembly, interpretation, and communication tool designed to support the translation of pathway-specific mechanistic data into responses relevant to assessing and managing risks of chemicals to human health and the environment. As such, AOPs facilitate the use of data streams often not employed by risk assessors, including information from in silico models, in vitro assays and short-term in vivo tests with molecular/biochemical endpoints. This translational capability can increase the capacity and efficiency of safety assessments both for single chemicals and chemical mixtures. Our mini-review describes the conceptual basis of the AOP framework and aspects of its current status relative to use by toxicologists and risk assessors, including four illustrative applications of the framework to diverse assessment scenarios.

• Publication year

  2018

• Venue

  Current Opinion in Toxicology

• Publication date

  2018-06-01

• Fields of study

  Medicine, Chemistry, Environmental Science, Computer Science

• Identifiers
  DOI 10.1016/j.cotox.2018.03.004PMID 29682628PMCID PMC5906804
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An "EAR" on Environmental Surveillance and Monitoring: A Case Study on the Use of Exposure-Activity Ratios (EARs) to Prioritize Sites, Chemicals, and Bioactivities of Concern in Great Lakes Waters.

  2017cited by this paper
• Using adaptive processes and adverse outcome pathways to develop meaningful, robust, and actionable environmental monitoring programs

  2017cited by this paper
• Advancing the adverse outcome pathway framework—An international horizon scanning approach

  2017cited by this paper
• Application of Adverse Outcome Pathways to U.S. EPA’s Endocrine Disruptor Screening Program

  2017cited by this paper
• Weight of evidence evaluation of a network of adverse outcome pathways linking activation of the nicotinic acetylcholine receptor in honey bees to colony death.

  2017cited by this paper
• The Role of Omics in the Application of Adverse Outcome Pathways for Chemical Risk Assessment

  2017cited by this paper
• Practical approaches to adverse outcome pathway development and weight‐of‐evidence evaluation as illustrated by ecotoxicological case studies

  2017cited by this paper
• Facilitating Translational Nanomedicine via Predictive Safety Assessment.

  2017cited by this paper
• Prediction of Chemical Multi-target Profiles and Adverse Outcomes with Systems Toxicology.

  2017cited by this paper
• Drug Metabolism in Preclinical Drug Development: A Survey of the Discovery Process, Toxicology, and Computational Tools.

  2017cited by this paper
• Quantitative Adverse Outcome Pathways and Their Application to Predictive Toxicology.

  2017cited by this paper
• Advancing alternatives analysis: The role of predictive toxicology in selecting safer chemical products and processes

  2017cited by this paper
• A comprehensive framework for evaluating the environmental health and safety implications of engineered nanomaterials

  2017cited by this paper
• Chemical exposure and infant leukaemia: development of an adverse outcome pathway (AOP) for aetiology and risk assessment research

  2017cited by this paper
• Adverse outcome pathways: a concise introduction for toxicologists

  2017cited by this paper
• Environmental surveillance and monitoring—The next frontiers for high‐throughput toxicology

  2016cited by this paper
• Limitations of toxicity characterization in life cycle assessment: Can adverse outcome pathways provide a new foundation?

  2016cited by this paper
• Personalized in vitro cancer models to predict therapeutic response: Challenges and a framework for improvement.

  2016cited by this paper
• A weight of evidence assessment approach for adverse outcome pathways.

  2016cited by this paper
• How Adverse Outcome Pathways Can Aid the Development and Use of Computational Prediction Models for Regulatory Toxicology

  2016cited by this paper
• Accelerating Adverse Outcome Pathway Development Using Publicly Available Data Sources

  2016cited by this paper
• The Adverse Outcome Pathway for Skin Sensitisation: Moving Closer to Replacing Animal Testing

  2016cited by this paper
• A History of the Molecular Initiating Event.

  2016cited by this paper
• The Adverse Outcome Pathway Concept: A Basis for Developing Regulatory Decision-making Tools

  2016influential reference
• The principle of safety evaluation in medicinal drug - how can toxicology contribute to drug discovery and development as a multidisciplinary science?

  2016cited by this paper
• The Frank R. Lautenberg Chemical Safety for the 21st Century Act

  2016cited by this paper
• The potential of AOP networks for reproductive and developmental toxicity assay development.

  2015cited by this paper
• Toward the Replacement of Animal Experiments through the Bioinformatics-driven Analysis of ‘Omics’ Data from Human Cell Cultures

  2015cited by this paper
• Nano-risk Science: application of toxicogenomics in an adverse outcome pathway framework for risk assessment of multi-walled carbon nanotubes

  2015cited by this paper
• Linking mechanistic toxicology to population models in forecasting recovery from chemical stress: A case study from Jackfish Bay, Ontario, Canada

  2015cited by this paper
• Adverse Outcome Pathways for Regulatory Applications: Examination of Four Case Studies With Different Degrees of Completeness and Scientific Confidence.

  2015cited by this paper
• Integrating basic radiobiological science and epidemiological studies: why and how.

  2015cited by this paper
• The Adverse Outcome Pathway: A Conceptual Framework to Support Toxicity Testing in the Twenty-First Century

  2015cited by this paper
• Proposing a scientific confidence framework to help support the application of adverse outcome pathways for regulatory purposes.

  2015cited by this paper
• A restatement of recent advances in the natural science evidence base concerning neonicotinoid insecticides and insect pollinators

  2015cited by this paper
• Increasing Scientific Confidence in Adverse Outcome Pathways: Application of Tailored Bradford-Hill Considerations for Evaluating Weight of Evidence.

  2015cited by this paper
• Are adverse outcome pathways here to stay?

  2015cited by this paper
• Screening Chemicals for Estrogen Receptor Bioactivity Using a Computational Model.

  2015cited by this paper
• Adverse outcome pathway (AOP) development I: strategies and principles.

  2014cited by this paper
• Applying the skin sensitisation adverse outcome pathway (AOP) to quantitative risk assessment.

  2014cited by this paper
• Open source software implementation of an integrated testing strategy for skin sensitization potency based on a Bayesian network.

  2014cited by this paper
• Bayesian integrated testing strategy to assess skin sensitization potency: from theory to practice

  2013cited by this paper
• INTERACTIONS BETWEEN CHEMICAL AND CLIMATE STRESSORS: A ROLE FOR MECHANISTIC TOXICOLOGY IN ASSESSING CLIMATE CHANGE RISKS

  2012cited by this paper
• Vision & strategy: Predictive ecotoxicology in the 21st century

  2011cited by this paper
• Adverse outcome pathways and ecological risk assessment: Bridging to population‐level effects

  2011cited by this paper
• Agency

  2010cited by this paper
• Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment

  2010cited by this paper
• Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go.

  2008cited by this paper
• Toxicity testing in the 21st century: a vision and a strategy.

  2007cited by this paper
• The organisation for economic cooperation and development

  2004cited by this paper

• Development and Analysis of the Adverse Outcome Pathway Network for Neurotoxicity.

  2026cites this paper
• High-Throughput Toxicity Screening with C. elegans: Current Platforms, Key Advantages, and Future Directions

  2026cites this paper
• Hierarchical Mechanistic Modeling of Complex Toxicity Endpoints from Public Concentration–Response Data

  2026cites this paper
• Weighted network analysis of adverse outcome pathways decodes the multiscale mechanisms of environmental toxicity

  2026cites this paper
• Computational standards and tools for exposome-wide association studies linking the human exposome with health outcomes.

  2026cites this paper
• Development of an integrative cross-omics approach for conceptual adverse outcome pathway network construction.

  2026cites this paper
• Epidemiological relevant effect biomarkers for thyroid hormone system related adverse outcome pathways: a literature review

  2026cites this paper
• Advancing translational exposomics: bridging genome, exposome and personalized medicine

  2025cites this paper
• Mass Spectrometry Proteomics: A Key to Faster Drug Discovery

  2025cites this paper
• Deep Learning-Based Screening of Zebrafish Embryo Malformations for Assessing the Developmental Toxicity and EC50 Estimation of Disinfection By-Products

  2025cites this paper
• Linking chemical data from the Comparative Toxicogenomics Database with adverse outcome pathways from the AOP-Wiki: a mechanistic data-oriented approach to help inform environmental health

  2025cites this paper
• A pragmatic upstream network for disrupted steroidogenesis through reduced enzyme activity and steroid hormone production for Adverse Outcome Pathway building.

  2025cites this paper
• Network toxicology and molecular docking to investigate the association of perfluorooctane sulfonate and pulmonary arterial hypertension via adverse outcome pathways.

  2025cites this paper
• In chemico toxicity approaches to assess, identify and prioritize contaminants in water

  2025cites this paper
• Application of Mechanistic Mathematical Modeling to Toxicology: Quantitative Systems Toxicology (QST).

  2025cites this paper
• Advancing Genotoxicity Assessment by Building a Global AOP Network

  2025cites this paper
• Mathematical modelling reveals compound-specific stress pathway activity.

  2025cites this paper
• Adverse Outcome Pathway (AOP) Coaching Program-How it functions and contributes to a more harmonized approach to AOP development and construction of AOP networks with regulatory utility.

  2025cites this paper
• Health impacts of exposure to synthetic chemicals in food

  2025cites this paper
• Are Behavioral Ecotoxicity Endpoints Relevant at the Population Level? Evidence-Based Insights for Environmental Protection

  2025cites this paper
• Eco-genotoxicology: A personal reflection.

  2025cites this paper
• The connection between Bayesian networks and adverse outcome pathway (AOP) networks and how to use it for predicting drug toxicity.

  2025cites this paper
• INSIGHT: An integrated framework for safe and sustainable chemical and material assessment

  2025cites this paper
• Nanomaterial grouping: Unraveling the relationship of induced mechanisms and potency at a temporal scale

  2025cites this paper
• Integrative Assessment of Mixture Toxicity of Household Chemicals Using the Toxic Unit Approach and Mode of Action.

  2025cites this paper
• Dynamics in zebrafish development define transcriptomic specificity after angiogenesis inhibitor exposure

  2025cites this paper
• Advancing the quantitative understanding of adverse outcome pathways: current status, methodologies, and future directions.

  2025cites this paper
• AOP Report: Development of an adverse outcome pathway for deposition of energy leading to bone loss

  2024cites this paper
• Effects of per- and polyfluoroalkyl substances on the liver: Human-relevant mechanisms of toxicity.

  2024cites this paper
• Some features of toxicological properties of a specific immunobiostimulator “Transfer factor” in preclinical trials

  2024cites this paper
• Knowledge-based machine learning for predicting and understanding the androgen receptor (AR)-mediated reproductive toxicity in zebrafish.

  2024cites this paper
• Transforming environmental health datasets from the comparative toxicogenomics database into chord diagrams to visualize molecular mechanisms

  2024cites this paper
• E‐waste: mechanisms of toxicity and safety testing

  2024cites this paper
• Potential Hazards of Polycyclic Aromatic Hydrocarbons in Great Lakes Tributaries Using Water Column and Porewater Passive Samplers and Sediment Equilibrium Partitioning

  2024cites this paper
• Investigation of parenteral nutrition-induced hepatotoxicity using human liver spheroid co-cultures

  2024cites this paper
• Building an adverse outcome pathway network for estrogen-, androgen- and steroidogenesis-mediated reproductive toxicity

  2024cites this paper
• The new normal chemical landscape: the future of risk assessment toward optimum consumer safety.

  2024cites this paper
• A comprehensive review on the application of socio-economic analyses in chemical management: Challenges and opportunities

  2024cites this paper
• Environmental realism in molecular ecotoxicology: key considerations to transition experimental data to ecologically relevant scenarios

  2024cites this paper
• Preliminary Toxicological Analysis in a Safe-by-Design and Adverse Outcome Pathway-Driven Approach on Different Silver Nanoparticles: Assessment of Acute Responses in A549 Cells

  2023cites this paper
• CTD Tetramers: a new online tool that computationally links curated chemicals, genes, phenotypes, and diseases to inform molecular mechanisms for environmental health.

  2023cites this paper
• A walk in the PARC: developing and implementing 21st century chemical risk assessment in Europe

  2023influential citation
• Deep Learning in Environmental Toxicology: Current Progress and Open Challenges

  2023cites this paper
• Invited Perspective: Reference Values à la Mode of Action

  2023cites this paper
• In Vitro Biodescriptors Derived from Time Series Toxicogenomics Data in In Silico QSAR Improve the Phenotypic Toxicity Prediction

  2023cites this paper
• An Adverse Outcome Pathway for Chemical-induced Parkinson's disease: Calcium is Key.

  2023cites this paper
• Diuron and its metabolites induce mitochondrial dysfunction-mediated cytotoxicity in urothelial cells

  2023cites this paper
• Optimization of an adverse outcome pathway network on chemical-induced cholestasis using an artificial intelligence-assisted data collection and confidence level quantification approach

  2023cites this paper
• Mechanistic insight into the adverse outcome of tire wear and road particle leachate exposure in zebrafish (Danio rerio) larvae.

  2023cites this paper
• Putative adverse outcome pathway development based on physiological responses of female fathead minnows to model estrogen versus androgen receptor agonists.

  2023cites this paper
• Multi-omic responses of fish exposed to complex chemical mixtures in the Shenandoah River watershed.

  2023cites this paper
• Artificial intelligence-driven drug development against autoimmune diseases.

  2023cites this paper
• Investigating fatty liver disease-associated adverse outcome pathways of perfluorooctane sulfonate using a systems toxicology approach.

  2023cites this paper
• Correlation Analysis of Variables From the Atherosclerosis Risk in Communities Study

  2022cites this paper
• A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessment.

  2022cites this paper
• Adverse Outcome Pathways as Versatile Tools in Liver Toxicity Testing.

  2022cites this paper
• Transcriptomic profiling of clobetasol propionate-induced immunosuppression in challenged zebrafish embryos.

  2022cites this paper
• Mapping Mechanistic Pathways of Acute Oral Systemic Toxicity Using Chemical Structure and Bioactivity Measurements

  2022cites this paper
• Application of Evidence-Based Methods to Construct Mechanism-Driven Chemical Assessment Frameworks

  2022cites this paper
• Using alternative test methods to predict endocrine disruption and reproductive adverse outcomes: do we have enough knowledge?

  2022cites this paper
• Linking Micropollutants to Trait Syndromes across Freshwater Diatom, Macroinvertebrate, and Fish Assemblages

  2022cites this paper
• Nongenomic effects and mechanistic study of butyl benzyl phthalate-induced thyroid disruption: Based on integrated in vitro, in silico assays and proteome analysis.

  2022cites this paper
• In Silico Identification of Potential Thyroid Hormone System Disruptors among Chemicals in Human Serum and Chemicals with a High Exposure Index

  2022cites this paper
• The exposome as the science of social-to-biological transitions.

  2022cites this paper
• Artificial Intelligence-Based Toxicity Prediction of Environmental Chemicals: Future Directions for Chemical Management Applications.

  2022cites this paper
• Editorial: Methods and Protocols in Developmental and Reproductive Toxicology

  2022cites this paper
• The Effects of Commercial Pesticide Formulations on the Function of In Vitro and In Vivo Assay Systems: A Comparative Analysis

  2022cites this paper
• Editorial: New mechanistic insight into perinatal origins of reproductive disorders caused by chemical exposures

  2022cites this paper
• A Putative Adverse Outcome Pathway Network for Disrupted Female Pubertal Onset to Improve Testing and Regulation of Endocrine Disrupting Chemicals

  2021cites this paper
• Combined In Vitro and In Vivo Approaches to Propose a Putative Adverse Outcome Pathway for Acute Lung Inflammation Induced by Nanoparticles: A Study on Carbon Dots

  2021cites this paper
• Non-additive gene interactions underpin molecular and phenotypic responses in honey bee larvae exposed to imidacloprid and thymol.

  2021cites this paper
• Evidenced-Based Approaches to Support the Development of Endocrine-Mediated Adverse Outcome Pathways: Challenges and Opportunities

  2021cites this paper
• Comparative analysis of transcriptomic points-of-departure (tPODs) and apical responses in embryo-larval fathead minnows exposed to fluoxetine.

  2021cites this paper
• Impact of environmental chemicals and endocrine disruptors on mammalian germ cell epigenome

  2021cites this paper
• Towards a qAOP framework for predictive toxicology - Linking data to decisions

  2021cites this paper
• Retinaldehyde Dehydrogenase Inhibition-Related Adverse Outcome Pathway: Potential Risk of Retinoic Acid Synthesis Inhibition during Embryogenesis

  2021cites this paper
• Transient exposure to sublethal concentrations of a pesticide mixture (chlorpyrifos-difenoconazole) caused different responses in fish species from different trophic levels of the same community.

  2021cites this paper
• Machine learning-based biomarkers identification from toxicogenomics - Bridging to regulatory relevant phenotypic endpoints.

  2021cites this paper
• Revealing Adverse Outcome Pathways from Public High-Throughput Screening Data to Evaluate New Toxicants by a Knowledge-Based Deep Neural Network Approach.

  2021cites this paper
• Assessing the Toxicity of 17α-Ethinylestradiol in Rainbow Trout Using a 4-Day Transcriptomics Benchmark Dose (BMD) Embryo Assay.

  2021cites this paper
• Pilot-scale expanded assessment of inorganic and organic tapwater exposures and predicted effects in Puerto Rico, USA

  2021cites this paper
• Investigation of a derived adverse outcome pathway (AOP) network for endocrine-mediated perturbations

  2021cites this paper
• Application of the adverse outcome pathway framework to predict the toxicity of chemicals in the semiconductor manufacturing industry

  2021influential citation
• In Vitro Three-Dimensional Liver Models for Nanomaterial DNA Damage Assessment.

  2021cites this paper
• CTD anatomy: Analyzing chemical-induced phenotypes and exposures from an anatomical perspective, with implications for environmental health studies

  2021cites this paper
• Drug development

  2020cites this paper
• Evaluation of Potential Risks to Human Health and Ecosystems During Exposure to Discarded Laboratory Chemical Mixtures by In Vitro Multimodel Approach

  2020cites this paper
• Leveraging the Comparative Toxicogenomics Database to fill in knowledge gaps for environmental health: a test case for air pollution-induced cardiovascular disease.

  2020cites this paper
• Putative adverse outcome pathways for female reproductive disorders to improve testing and regulation of chemicals

  2020cites this paper
• Toward an AOP network-based tiered testing strategy for the assessment of thyroid hormone disruption.

  2020cites this paper
• Variability in in vivo studies: Defining the upper limit of performance for predictions of systemic effect levels.

  2020cites this paper
• Retinoids and Developmental Neurotoxicity: utilizing toxicogenomics to enhance adverse outcome pathways and testing strategies.

  2020cites this paper
• Adverse outcome pathways as a tool for the design of testing strategies to support the safety assessment of emerging advanced materials at the nanoscale

  2020cites this paper
• Polyps of the Jellyfish Aurelia aurita Are Unaffected by Chronic Exposure to a Combination of Pesticides

  2020cites this paper
• A case study applying pathway-oriented thinking to problem formulation for planning a systematic review.

  2020cites this paper
• Organizing mechanism-related information on chemical interactions using a framework based on the aggregate exposure and adverse outcome pathways

  2020cites this paper
• Developmental biology meets toxicology: contributing reproductive mechanisms to build Adverse Outcome Pathways.

  2020cites this paper
• Toward Rigorous Materials Production: New Approach Methodologies Have Extensive Potential to Improve Current Safety Assessment Practices.

  2020cites this paper
• Machine Learning-based Biomarkers Identification and Validation from Toxicogenomics - Bridging to Regulatory Relevant Phenotypic Endpoints

  2020cites this paper
• Toxicogenomic fin(ger)prints for thyroid disruption AOP refinement and biomarker identification in zebrafish embryos.

  2020cites this paper